• Profile
Close

Dexmedetomidine as a part of general anaesthesia for caesarean delivery in patients with pre-eclampsia: A randomised double-blinded trial

European Journal of Anaesthesiology Apr 08, 2018

Eskandr AM, et al. - Whether dexmedetomidine reduces both the stress response and the haemodynamic response to tracheal intubation when administered as a part of general anaesthesia in patients with pre-eclampsia undergoing caesarean delivery, was investigated. Based on dexmedetomidine dosing, three groups were examined: Groups D1and D2 received an infusion of dexmedetomidine 1 μg kg-1 over the 10 min before induction of general anaesthesia, then 0.4 and 0.6 μg kg-1 h-1 dexmedetomidine, respectively. Group C received equivalent volumes of 0.9% saline. Without causing significant adverse neonatal outcome, dexmedetomidine was shown to be related to haemodynamic and hormonal stability when administered in doses 0.4 and 0.6 μg kg-1 h-1.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay